EndoRetics is commercializing an endolumenal incisionless reversible bariatric device for the treatment of obesity.
Obesity is a growing global epidemic without sufficient treatments. The EndoRetics device will provide surgeons and gastroenterologists with the ability to create a small gastric pouch in the upper stomach without the need for a surgery suite and no general anesthetic. The low cost, reversible, incisionless procedure will be performed on an outpatient basis. Easy transferability will allow more physicians to treat patients for obesity.